Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers†

Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection

(2016) Clara Bayarri-Lara et al.   PLoS One

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Detection of Circulating Tumor Cells from Lung Cancer Patients in the Era of Targeted Therapy : Promises, Drawbacks and Pitfalls

(2014) V. Hofman et al.   CURRENT MOLECULAR MEDICINE

Value of Metabolic Tumor Volume on Repeated 18F-FDG PET/CT for Early Prediction of Survival in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

(2014) W. Huang et al.   JOURNAL OF NUCLEAR MEDICINE

Biomarkers in Early-Stage Non–Small-Cell Lung Cancer: Current Concepts and Future Directions

(2014) Mauricio Burotto et al.   Journal of Thoracic Oncology

Molecular analysis of circulating tumour cells—biology and biomarkers

(2014) Matthew G. Krebs et al.   Nature Reviews Clinical Oncology

Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer

(2014) Masaki Hashimoto et al.   Interactive Cardiovascular and Thoracic Surgery

The impact of the sequence of pulmonary vessel ligation during anatomic resection for lung cancer on long-term survival – a prospective randomized trial

(2013) A Kozak et al.   Advances in Medical Sciences

Prognostic Significance of Circulating Tumor Cells in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis

(2013) Jianwei Huang et al.   PLoS One

Results of Long-Term Follow-Up of Patients With Completely Resected Non-Small Cell Lung Cancer

(2012) Chiaki Endo et al.   ANNALS OF THORACIC SURGERY

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

(2012) E. A. Punnoose et al.   CLINICAL CANCER RESEARCH

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

(2011) Matthew G. Krebs et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating Tumor Cells and PET

(2011) J. Q. Yu et al.   JOURNAL OF NUCLEAR MEDICINE

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer

(2011) John D. O’Flaherty et al.   LUNG CANCER

Detection of circulating tumor Cells in the context of treatment: Prognostic value in breast cancer patients

(2010) Maria Jose Serrano et al.   CANCER BIOLOGY & THERAPY

Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

(2010) V. Hofman et al.   CLINICAL CANCER RESEARCH

Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer: Update of a Systematic Review and Meta-Analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project

(2010) Marianne Paesmans et al.   Journal of Thoracic Oncology

TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients

(2010) Sun Och Yoon et al.   LUNG CANCER

Factors associated with recurrence in patients with curatively resected stage I–II lung cancer

(2010) Hyeon-Kyoung Koo et al.   LUNG CANCER

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer

(2009) U. De Giorgi et al.   ANNALS OF ONCOLOGY

Relationship Between Non-small Cell Lung Cancer FDG Uptake at PET, Tumor Histology, and Ki-67 Proliferation Index

(2008) Hubert Vesselle et al.   Journal of Thoracic Oncology